Neuromuscular monitoring

Last updated
Simple subjective Peripheral Nerve stimulator Relaxometer fisher.jpg
Simple subjective Peripheral Nerve stimulator
Quantitative electromyographic recording at adductor pollicis muscle and stimulation of the ulnar nerve Electromyographic recording at adductor pollicis muscle and stimulation of the ulnar nerve.jpg
Quantitative electromyographic recording at adductor pollicis muscle and stimulation of the ulnar nerve

In anesthesia, neuromuscular blocking agents may be required to facilitate endotracheal intubation and provide optimal surgical conditions. When neuromuscular blocking agents are administered, neuromuscular function of the patient must be monitored. [1] Neuromuscular function monitoring is a technique that involves the electrical stimulation of a motor nerve and monitoring the response of the muscle supplied by that nerve. [2] It may be used from the induction of to recovery from neuromuscular blockade. Importantly, it is used to confirm adequacy of recovery after the administration of neuromuscular blocking agents. [3] The response of the muscles to electrical stimulation of the nerves can be recorded subjectively (qualitative) or objectively (quantitatively). Quantitative techniques include electromyography, acceleromyography, kinemyography, phonomygraphy and mechanomyography. Neuromuscular monitoring is recommended when neuromuscular-blocking drugs have been part of the general anesthesia and the doctor wishes to avoid postoperative residual curarization (PORC) in the patient, that is, the residual paralysis of muscles stemming from these drugs.[ citation needed ]

Contents

When train of four monitoring is "used continuously, each set (train) of stimuli normally is repeated every 10th to 12th second. Each stimulus in the train causes the muscle to contract, and 'fade' in the response provides the basis for evaluation." These sets are called trains because their shape bears the resemblance of a train. [4] In train of four monitoring, "peripheral nerve stimulation can ensure proper medication dosing and thus decrease the incidence of side effects" by "assessing the depth of neuromuscular blockade". [5]

Before the patient is fully awake, voluntary muscle testing is not possible and indirect clinical tests, such as apparent muscle tone and pulmonary compliance, can be affected by factors other than PORC. Direct neuromuscular monitoring avoids these problems and allows the doctor to remedy PORC before it becomes a source of patient distress. [6] [7] [8] [9] [10]

Patterns of nerve stimulation

Various nerve stimulation patterns may be used in neuromuscular function monitoring and the response to these stimulation patterns is used to assess the depth of neuromuscular blockade.

Some patterns of stimulation used today include, single twitch (ST), train-of four (TOF), [11] double burst stimulation (DBS), tetanic stimulation

and the post tetanic count. [12]

Monitoring the response of the muscle to nerve stimulation

The response of the muscle to stimulation of the nerve supplying it can be assessed by subjective (visual or tactile) techniques or quantitative (objective) devices that provide a numeric value relating to the depth of neuromuscular blockade.

Quantitative (objective) neuromuscular monitors

Quantitative neuromuscular monitors can be subdivided into monitors that measure the electrical response, the compound evoked muscle action potential, and those that monitor the contractile response to stimulation. The measurement of the electrical response to muscle stimulation is called electromyography. The mechanical response to stimulation of the muscle can be measured by mechanomyography, kinemyography and acceleromyography [13]

Quantitative acceleromyographic neuromuscular monitor with stimulating electrodes over the ulnar nerve and the piezoelectric crystal that measures acceleration on the thumb with hand adapter. Acceleromyography monitoring with preload hand adapter.jpg
Quantitative acceleromyographic neuromuscular monitor with stimulating electrodes over the ulnar nerve and the piezoelectric crystal that measures acceleration on the thumb with hand adapter.

Consensus Statement on Perioperative Use of Neuromuscular Monitoring

In 2018 recommendations by an international panel of experts on neuromuscular monitoring to assist anaesthesia care providers and professional organisations that develop practice advisories and guidelines regarding the minimum standards for monitoring patients that receive neuromuscular blockade (NMB) during anaesthesia. The recommendations include the following:[ citation needed ]

  1. "Quantitative (objective) NMB monitoring should be used whenever non-depolarising neuromuscular blocking drug is administered."
  2. "Subjective or clinical tests of NMB are not predictive of adequate neuromuscular recovery and are not sensitive to detect residual weakness; their use should be abandoned in favour of quantitative (objective) monitoring."
  3. "Professional organisations should develop practice standards and guidelines detailing how best to monitor and manage perioperative administration of NMBDs."
  4. "Terms that describe the levels of NMB should be standardised. New proposed definitions are published in the consensus statement based on quantitative NMB monitoring criteria." [14]

Anaesthetic organisations with guidelines or professional standards on neuromuscular monitoring

Quantitative acceleromyographic neuromuscular monitor with preload hand adapter. Relaxometer trident.jpg
Quantitative acceleromyographic neuromuscular monitor with preload hand adapter.

The Association of Anaesthetists of Great Britain and Ireland published recommendations for standards of monitoring during anaesthesia and recovery in 2015. [15] These included that a peripheral nerve stimulator is mandatory for all patients receiving neuromuscular blocking drugs and that they should be applied and used from induction (to confirm adequate muscle relaxation before intubation) until recovery from blockade and return of consciousness. They state that a more reliable guarantee of return of safe motor function is a train of four ratio of greater than 0.9. A quantitative neuromuscular monitor is required to accurately assess the train of four ratio. [16]

The Australian and New Zealand College of Anaesthetists also publishes professional standards and guidelines on monitoring during anaesthesia. In respect to neuromuscular function monitoring - They state " Neuromuscular function monitoring, preferably quantitative, must be available for every patient in whom neuromuscular blockade is induced and should be used whenever the anaesthetist is considering extubation following the use of non-depolarising neuromuscular blockade." [17]

Related Research Articles

Anesthesia is a state of controlled, temporary loss of sensation or awareness that is induced for medical or veterinary purposes. It may include some or all of analgesia, paralysis, amnesia, and unconsciousness. An individual under the effects of anesthetic drugs is referred to as being anesthetized.

Local anesthesia is any technique to induce the absence of sensation in a specific part of the body, generally for the aim of inducing local analgesia, that is, local insensitivity to pain, although other local senses may be affected as well. It allows patients to undergo surgical and dental procedures with reduced pain and distress. In many situations, such as cesarean section, it is safer and therefore superior to general anesthesia.

<span class="mw-page-title-main">Local anesthetic</span> Medications to reversibly block pain

A local anesthetic (LA) is a medication that causes absence of pain sensation. In the context of surgery, a local anesthetic creates an absence of pain in a specific location of the body without a loss of consciousness, as opposed to a general anesthetic. When it is used on specific nerve pathways, paralysis also can be achieved.

<span class="mw-page-title-main">General anaesthesia</span> Medically induced coma

General anaesthesia (UK) or general anesthesia (US) is a medically induced loss of consciousness that renders the patient unarousable even with painful stimuli. This effect is achieved by administering either intravenous or inhalational general anaesthetic medications, which often act in combination with an analgesic and neuromuscular blocking agent. Spontaneous ventilation is often inadequate during the procedure and intervention is often necessary to protect the airway. General anaesthesia is generally performed in an operating theater to allow surgical procedures that would otherwise be intolerably painful for a patient, or in an intensive care unit or emergency department to facilitate endotracheal intubation and mechanical ventilation in critically ill patients.

<span class="mw-page-title-main">Anesthesiology</span> Medical specialty concerned with anesthesia and perioperative care

Anesthesiology, anaesthesiology, or anaesthesia is the medical specialty concerned with the total perioperative care of patients before, during and after surgery. It encompasses anesthesia, intensive care medicine, critical emergency medicine, and pain medicine. A physician specialized in anesthesiology is called an anesthesiologist, anaesthesiologist, or anaesthetist, depending on the country. In some countries, the terms are synonymous, while in other countries they refer to different positions, and anesthetist is only used for non-physicians, such as nurse anesthetists.

<span class="mw-page-title-main">Spinal anaesthesia</span> Form of neuraxial regional anaesthesia

Spinal anaesthesia, also called spinal block, subarachnoid block, intradural block and intrathecal block, is a form of neuraxial regional anaesthesia involving the injection of a local anaesthetic or opioid into the subarachnoid space, generally through a fine needle, usually 9 cm (3.5 in) long. It is a safe and effective form of anesthesia usually performed by anesthesiologists that can be used as an alternative to general anesthesia commonly in surgeries involving the lower extremities and surgeries below the umbilicus. The local anesthetic with or without an opioid injected into the cerebrospinal fluid provides locoregional anaesthesia: true analgesia, motor, sensory and autonomic (sympathic) blockade. Administering analgesics in the cerebrospinal fluid without a local anaesthetic produces locoregional analgesia: markedly reduced pain sensation, some autonomic blockade, but no sensory or motor block. Locoregional analgesia, due to mainly the absence of motor and sympathic block may be preferred over locoregional anaesthesia in some postoperative care settings. The tip of the spinal needle has a point or small bevel. Recently, pencil point needles have been made available.

Awareness under anesthesia, also referred to as intraoperative awareness or accidental awareness during general anesthesia (AAGA), is a rare complication of general anesthesia where patients regain varying levels of consciousness during their surgical procedures. While anesthesia awareness is possible without resulting in any long-term memory, it is also possible for the victim to have awareness with explicit recall, where victims can remember the events related to their surgery.

<span class="mw-page-title-main">Bispectral index</span>

Bispectral index (BIS) is one of several technologies used to monitor depth of anesthesia. BIS monitors are used to supplement Guedel's classification system for determining depth of anesthesia. Titrating anesthetic agents to a specific bispectral index during general anesthesia in adults allows the anesthetist to adjust the amount of anesthetic agent to the needs of the patient, possibly resulting in a more rapid emergence from anesthesia. Use of the BIS monitor could reduce the incidence of intraoperative awareness during anaesthesia. The exact details of the algorithm used to create the BIS index have not been disclosed by the company that developed it.

In advanced airway management, rapid sequence induction (RSI) – also referred to as rapid sequence intubation or as rapid sequence induction and intubation (RSII) or as crash induction – is a special process for endotracheal intubation that is used where the patient is at a high risk of pulmonary aspiration. It differs from other techniques for inducing general anesthesia in that several extra precautions are taken to minimize the time between giving the induction drugs and securing the tube, during which period the patient's airway is essentially unprotected.

<span class="mw-page-title-main">Tubocurarine chloride</span> Obsolete muscle relaxant

Tubocurarine is a toxic alkaloid historically known for its use as an arrow poison. In the mid-1900s, it was used in conjunction with an anesthetic to provide skeletal muscle relaxation during surgery or mechanical ventilation. It is now rarely used as an adjunct for clinical anesthesia because safer alternatives, such as cisatracurium and rocuronium, are available.

<span class="mw-page-title-main">Neuromuscular-blocking drug</span> Type of paralyzing anesthetic including lepto- and pachycurares

Neuromuscular-blocking drugs block neuromuscular transmission at the neuromuscular junction, causing paralysis of the affected skeletal muscles. This is accomplished via their action on the post-synaptic acetylcholine (Nm) receptors.

<span class="mw-page-title-main">Atracurium besilate</span> Chemical compound

Atracurium besilate, also known as atracurium besylate, is a medication used in addition to other medications to provide skeletal muscle relaxation during surgery or mechanical ventilation. It can also be used to help with endotracheal intubation but suxamethonium (succinylcholine) is generally preferred if this needs to be done quickly. It is given by injection into a vein. Effects are greatest at about 4 minutes and last for up to an hour.

<span class="mw-page-title-main">Sugammadex</span> Selective relaxant binding agent

Sugammadex, sold under the brand name Bridion, is a medication for the reversal of neuromuscular blockade induced by rocuronium and vecuronium in general anaesthesia. It is the first selective relaxant binding agent (SRBA). It is marketed by Merck.

Guedel's classification is a means of assessing of depth of general anesthesia introduced by Arthur Ernest Guedel (1883-1956) in 1920.

<span class="mw-page-title-main">Gantacurium chloride</span>

Gantacurium chloride is a new experimental neuromuscular blocking drug or skeletal muscle relaxant in the category of non-depolarizing neuromuscular-blocking drugs, used adjunctively in surgical anesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. Gantacurium is not yet available for widespread clinical use: it is currently undergoing Phase III clinical development.

<span class="mw-page-title-main">Brachial plexus block</span>

Brachial plexus block is a regional anesthesia technique that is sometimes employed as an alternative or as an adjunct to general anesthesia for surgery of the upper extremity. This technique involves the injection of local anesthetic agents in close proximity to the brachial plexus, temporarily blocking the sensation and ability to move the upper extremity. The subject can remain awake during the ensuing surgical procedure, or they can be sedated or even fully anesthetized if necessary.

<span class="mw-page-title-main">Acceleromyograph</span> Used to measure the force produced by a muscle

An acceleromyograph is a piezoelectric myograph, used to measure the force produced by a muscle after it has undergone nerve stimulation. Acceleromyographs may be used, during anaesthesia when muscle relaxants are administered, to measure the depth of neuromuscular blockade and to assess adequacy of recovery from these agents at the end of surgery. Acceleromyography is classified as quantitative neuromuscular monitoring.

<span class="mw-page-title-main">Postoperative residual curarization</span> Medical condition

Postoperative residual curarization (PORC) or residual neuromuscular blockade (RNMB) is a residual paresis after emergence from general anesthesia that may occur with the use of neuromuscular-blocking drugs. Today residual neuromuscular blockade is defined as a train of four ratio of less than 0.9 when measuring the response to ulnar nerve stimulation at the adductor pollicis muscle using mechanomyography or electromyography. A meta-analysis reported that the incidence of residual neuromuscular paralysis was 41% in patients receiving intermediate neuromuscular blocking agents during anaesthesia. It is possible that > 100,000 patients annually in the USA alone, are at risk of adverse events associated with undetected residual neuromuscular blockade. Neuromuscular function monitoring and the use of the appropriate dosage of sugammadex to reverse blockade produced by rocuronium can reduce the incidence of postoperative residual curarization. In this study, with usual care group receiving reversal with neostigmine resulted in a residual blockade rate of 43%.

The following outline is provided as an overview of and topical guide to anesthesia:

Neuromuscular blocking agents, or in abbreviation, NMBAs, are chemical agents that paralyse skeletal muscles by blocking the movement of neurotransmitter at the neuromuscular junction. They are often used during general anesthesia to optimize intubating and surgical conditions, specifically to facilitate endotracheal intubation. This class of medications helps to reduce patient movement, breathing, or ventilator dyssynchrony and allows lower insufflation pressures during laparoscopy including the generation of nerve impulses. It has several indications for use in the intense care unit. It can help reduce hoarseness in voice as well as injury to the vocal cord during intubation. In addition, it plays an important role in facilitating mechanical ventilation in patients with poor lung function. In the following section, neuromuscular blocking agent's history, usages, mechanisms, side effects, interactions and pharmacology will further be elaborated and discussed.

References

  1. Ortega R, Brull SJ, Prielipp R, Gutierrez A, De La Cruz R, Conley CM (January 2018). "Monitoring Neuromuscular Function". The New England Journal of Medicine. 378 (4): e6. doi:10.1056/NEJMvcm1603741. PMID   29365307.
  2. Naguib M, Brull SJ, Johnson KB (January 2017). "Conceptual and technical insights into the basis of neuromuscular monitoring". Anaesthesia. 72 Suppl 1 (S1): 16–37. doi: 10.1111/anae.13738 . PMID   28044330.
  3. Checketts MR, Alladi R, Ferguson K, Gemmell L, Handy JM, Klein AA, Love NJ, Misra U, Morris C, Nathanson MH, Rodney GE, Verma R, Pandit JJ (January 2016). "Recommendations for standards of monitoring during anaesthesia and recovery 2015: Association of Anaesthetists of Great Britain and Ireland". Anaesthesia. 71 (1): 85–93. doi:10.1111/anae.13316. PMC   5063182 . PMID   26582586.
  4. "Train-of-Four Stimulation". Churchill Livingstone. 2000. Archived from the original on 11 September 2014. Retrieved 10 September 2014.
  5. Saenz AD, Maillie S, Eiger G (12 July 2013). Spencer DC (ed.). "Peripheral Nerve Stimulator - Train of Four Monitoring". Medscape . Retrieved 10 September 2014.
  6. Viby-Mogensen J. "Chapter 39: Neuromuscular Monitoring" (PDF). Miller's Anesthesia (5th ed.). Churchill Livingstone, Inc.
  7. Harvey AM, Masland RL (1941). "Actions of durarizing preparations in the human". Journal of Pharmacology and Experimental Therapeutics. 73 (3): 304–311.
  8. Botelho SY (November 1955). "Comparison of simultaneously recorded electrical and mechanical activity in myasthenia gravis patients and in partially curarized normal humans". The American Journal of Medicine. 19 (5): 693–6. doi:10.1016/S0002-9343(55)80010-1. PMID   13268466.
  9. Christie TH, Churchill-Davidson HC (April 1958). "The St. Thomas's Hospital nerve stimulator in the diagnosis of prolonged apnoea". Lancet. 1 (7024): 776. doi:10.1016/s0140-6736(58)91583-6. PMID   13526270.
  10. Engbaek J, Ostergaard D, Viby-Mogensen J (March 1989). "Double burst stimulation (DBS): a new pattern of nerve stimulation to identify residual neuromuscular block". British Journal of Anaesthesia. 62 (3): 274–8. doi: 10.1093/bja/62.3.274 . PMID   2522790.
  11. ALI, HASSAN H.; UTTING, J.E.; GRAY, CECIL (November 1970). "Stimulus Frequency in the Detection of Neuromuscular Block in Humans". British Journal of Anaesthesia. 42 (11): 967–978. doi: 10.1093/bja/42.11.967 . ISSN   0007-0912. PMID   5488360.
  12. Ortega, Rafael; Brull, Sorin J.; Prielipp, Richard; Gutierrez, Alexander; de la Cruz, Rossemary; Conley, Christopher M. (2018). "Monitoring Neuromuscular Function | NEJM". New England Journal of Medicine. 378 (4): e6. doi:10.1056/nejmvcm1603741. PMID   29365307.
  13. Brull, Sorin J.; Kopman, Aaron F. (January 2017). "Current Status of Neuromuscular Reversal and Monitoring". Anesthesiology. 126 (1): 173–190. doi:10.1097/aln.0000000000001409. ISSN   0003-3022. PMID   27820709. S2CID   34444215.
  14. Naguib, Mohamed; Brull, Sorin J.; Kopman, Aaron F.; Hunter, Jennifer M.; Fülesdi, Béla; Arkes, Hal R.; Elstein, Arthur; Todd, Michael M.; Johnson, Ken B. (July 2018). "Consensus Statement on Perioperative Use of Neuromuscular Monitoring". Anesthesia & Analgesia. 127 (1): 71–80. doi: 10.1213/ane.0000000000002670 . ISSN   0003-2999. PMID   29200077.
  15. Checketts, M. R.; Alladi, R.; Ferguson, K.; Gemmell, L.; Handy, J. M.; Klein, A. A.; Love, N. J.; Misra, U.; Morris, C. (2016). "Recommendations for standards of monitoring during anaesthesia and recovery 2015 : Association of Anaesthetists of Great Britain and Ireland". Anaesthesia. 71 (1): 85–93. doi:10.1111/anae.13316. ISSN   1365-2044. PMC   5063182 . PMID   26582586.
  16. Hemmerling, Thomas M.; Le, Nhien (January 2007). "Brief review: Neuromuscular monitoring: an update for the clinician". Canadian Journal of Anesthesia. 54 (1): 58–72. doi: 10.1007/bf03021901 . ISSN   0832-610X. PMID   17197470.
  17. "Australian and New Zealand College of AnaesthetistsProfessional Standards 2017 PS18 Guidelines on monitoring during anaesthesia" (PDF).

Further reading